Michigan House Passes Kratom Ban, Sending Shockwaves Through Industry

Michigan House Passes Kratom Ban, Sending Shockwaves Through Industry

LANSING, MI – March 20, 2026 – The Michigan House of Representatives has passed House Bill 5537, a legislative measure that, if enacted, would outlaw the manufacturing, sale, and distribution of kratom and its synthetic derivatives across the state. The bill, approved on March 18, 2026, now moves to the Michigan Senate for further consideration, marking a critical juncture for the kratom industry and consumers in Michigan.

The proposed legislation amends the state's penal code to prohibit a wide array of activities involving Mitragyna speciosa, including growing, synthesizing, importing, and offering kratom for sale. It explicitly bans synthetic versions, such as 7-hydroxymitragynine, though it includes an exception for FDA-approved kratom products as drugs, dietary supplements, or food additives, an exemption that would not apply to synthetic variants. Violations of the ban would be classified as misdemeanors, carrying penalties of up to 90 days in jail and a $5,000 fine for a first offense, with escalating consequences for repeat offenses and sales to minors.

Why This Matters to Kratom Merchants and Consumers

For kratom merchants currently operating in Michigan, the passage of HB 5537 by the House signals an immediate and severe threat to their businesses. Should the bill become law, all sales and distribution of kratom would become illegal, forcing an immediate cessation of operations and potentially leading to criminal charges for non-compliance. Consumers in Michigan would lose access to a product many use for pain relief and mood enhancement, as highlighted by proponents of regulation over prohibition.

This legislative action in Michigan starkly contrasts with efforts in other states to implement the Kratom Consumer Protection Act (KCPA), which seeks to regulate kratom rather than ban it outright. The KCPA typically establishes age restrictions, mandates clear labeling, and requires lab testing to ensure product safety and purity. The Michigan bill, however, represents a complete prohibition, reflecting concerns from some lawmakers and health experts regarding addiction, safety, and the substance's marketing to young people. The FDA has not approved kratom for any medical use and lists it as a "drug and chemical of concern," contributing to the legislative push for bans.

Compliance Implications for High-Risk Merchants

For high-risk kratom merchants, the situation in Michigan underscores the unpredictable and often challenging regulatory environment surrounding kratom nationwide. Even for businesses operating in states where kratom remains legal, this development is a stark reminder of the importance of proactive compliance and robust quality control.

High-risk merchants must prioritize stringent adherence to quality and safety standards, even in the absence of explicit state-level KCPA regulations. This includes:

• Certificates of Analysis (COAs): Every batch of kratom should undergo independent third-party lab testing, with readily available COAs. These COAs should verify the product's alkaloid content, particularly mitragynine and 7-hydroxymitragynine, and confirm the absence of contaminants like heavy metals, pesticides, and microbial impurities.
• Comprehensive Lab Testing: Beyond basic screening, comprehensive lab testing should be a standard practice. This not only ensures product purity but also helps in accurately labeling products, which is a key component of consumer protection legislation like the KCPA.
• Regulatory Compliance Preparedness: Merchants should stay informed about legislative developments in all states where they operate or ship products. Given the varying approaches to kratom regulation—from outright bans to KCPA-style frameworks—flexibility and the ability to adapt quickly to new laws are crucial. This includes understanding and complying with any age restrictions, labeling requirements, and prohibitions on adulterated or contaminated products.

The Michigan House's decision to pass HB 5537 serves as a potent warning. While the bill still needs Senate approval and the Governor's signature to become law, it highlights the ongoing battle over kratom's legal status. For merchants, the path forward demands unwavering commitment to product safety, transparency, and a vigilant eye on the ever-evolving legal landscape.